Venus Remedies Ltd.

Financial

	Venus Remedies	Jenburkt Pharma	Prevest Denpro
Operational Metrics
Financials
5 yr Average ROE	6.64 %	18.49 %	23.02 %
5yr average Equity Multiplier	1.46	1.17	1.16
5yr Average Asset Turnover Ratio	0.89	0.88	0.69
5yr Avg Net Profit Margin	4.93 %	18.1 %	28.95 %
Price to Book	1.03	3.34	5.37
P/E	12.75	17.89	31.25
5yr Avg Cash Conversion Cycle	72.13 Days	-32.02 Days	57.55 Days
Inventory Days	93.66 Days	24.72 Days	26.01 Days
Days Receivable	47.69 Days	48.38 Days	50.74 Days
Days Payable	52.51 Days	82.6 Days	75.73 Days
5yr Average Interest Coverage Ratio	176.34	87.2	75.33
5yr Avg ROCE	6.96 %	24.44 %	30.18 %
5yr Avg Operating Profit Margin	10.58 %	22.46 %	36.73 %
5 yr average Debt to Equity	0.22	0.02	0.02
5yr CAGR Net Profit	n/a	14.21 %	17.49 %
5yr Average Return on Assets	5.11 %	15.8 %	19.63 %
Shareholdings
Promoter Holding	41.76 %	46.68 %	73.6 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.95 %	0.95 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Venus Remedies	Jenburkt Pharma	Prevest Denpro
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Dermatology 0 Dental Materials 0	Product Wise Break-Up Dental Materials 0 Dermatology 0 Pharmaceutical 100.0	Product Wise Break-Up Dental Materials 100.0 Dermatology 0 Pharmaceuticals 0
Location Wise Break-Up	Location Wise Break-Up India 33.0 Rest of the World 0 Lebanon 0 Morocco 0 Saudi Arabia 0 Indonesia 0 UK 0 South America 0 Oceania 0 Africa 0 Asia 0 North America 0 Europe 0 Others 67.0	Location Wise Break-Up Morocco 0 Oceania 0 Lebanon 0 UK 0 Asia 0 North America 0 Europe 0 India 85.66 Africa 0 South America 0 Indonesia 0 Saudi Arabia 0 Rest of the World 14.1 Others 0.24	Location Wise Break-Up Morocco 0 Oceania 0 Lebanon 0 UK 0 Asia 10.07 North America 0.22 Europe 27.02 India 38.91 Africa 18.0 South America 0.28 Indonesia 0 Saudi Arabia 0 Rest of the World 0 Others 5.5